Oleanolic acid initiates apoptosis in non-small cell lung cancer cell lines and reduces metastasis of a B16F10 melanoma model in vivo

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Lúcio, Kelly Araújo ^a   da Rocha, Gleice Graça ^a   Monção Ribeiro, Leonardo Campos ^a   Fernandes, Janaina ^a   Takiya, Christina Maeda ^a   Gattass, Cerli Rocha ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER C1; CASPASE 3; CISPLATIN; MULTIDRUG RESISTANCE PROTEIN 1; OLEANOLIC ACID; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; UNCLASSIFIED DRUG; VASCULOTROPIN; CASPASE; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG DOSE COMPARISON; HUMAN; HUMAN CELL; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MELANOMA B16; METASTASIS INHIBITION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL SURVIVAL; DRUG EFFECT; ENZYMOLOGY; LUNG TUMOR; MELANOMA; METABOLISM; METASTASIS; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; HUMANS; LUNG NEOPLASMS; MELANOMA; MICE; MICE, INBRED C57BL; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OLEANOLIC ACID; SIGNAL TRANSDUCTION;

EID: 83055199995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028596     Document Type: Article

References (44)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics. CA Cancer J Clin 57: 43-66.
2. Gao G, Jiang J, Liang X, Zhou X, Huang R, et al. (2009) A meta-analysis of platinum plus gencitabine or vinorelbine in the treatment on advanced non-small cell lung cancer. Lung Cancer 65: 339-344.
3. Reck M, Gatzemeir U, (2008) Advanced non-small cell lung cancer therapy: historical and future perspectives. Targ Oncol 3: 135-147.
4. Oshika Y, Nakamura M, Tokunaga T, Fukushima Y, Abe Y, et al. (1998) Multidrug resistance-associated protein and mutant p53 protein expression in non-small cell lung cancer. Mod Pathol 11: 1059-1063.
5. Li XQ, Li J, Shi SB, Chen P, Yu LC, et al. (2009) Expression of MRP1, BCRP, LRP and ERCC1 as prognostic factors in non-small cell lung cancer patients receiving postoperative cisplatin-based chemotherapy. Int J Biol Markers 24: 230-237.
6. Sharon FJ, (2008) ABC Multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9: 106-127.
7. Haura EB, Cress WD, Chellappan S, Zheng Z, Bepler G, (2004) Antiapoptotic signaling pathways in non-small-cell lung cancer: biology and therapeutic strategies. Clin Lung Cancer 6: 113-122.
8. Krepella E, Dankova P, Moravcikova E, Krepelova A, Prochazka J, et al. (2009) Increased expression of inihibitor of apoptosis protein survivin and XIAP in non-small cell lung carcinoma. Int J Oncol 35: 1449-1462.
9. Tse C, Shoemaker AR, Adickes J, Anderson MG, Chen J, et al. (2008) ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor. Cancer Res 68: 3421-3428.
10. Li J, Viallet J, Haura EB, (2008) A small molecule pan-Bcl2 family inhibitor, GX15-070 induces apoptosis and enhances cisplatin-induced apoptosis in non-small cell lung cancer. Cancer Chemother Pharmacol 61: 525-534.
11. Olie RA, Simoões-Wurst AP, Baumann B, Leech SH, Fabbro D, et al. (2000) A Novel Antisense Oligonucleotide Targeting Survivin Expression Induces Apoptosis and Sensitizes Lung Cancer Cells to Chemotherapy. Cancer Res 60: 2805-2809.
12. Dean EJ, Ward T, Pinilla C, Houghten R, Welsh K, et al. (2010) A small molecule inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. Br J Cancer 102: 97-103.
13. Folkman J, (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-18.
14. Berger W, Setinek U, Zidek PHT, Steiner E, Cantonati LEH, et al. (2005) J Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol 131: 355-363.
15. Cheng Y-J, Hang-Shiang JH-S, Hsu S-L, Lin L-C, Wu C-L, et al. (2010) XIAP-mediated protection of H460 lung cancer cells against cisplatin. Eur J Pharmacol 627: 75-84.
16. Singh GB, Singh S, Bani S, Gupta BD, Banerjee SK, et al. (1992) Anti-inflammatory activity of oleanolic acid in rats and mice. J Pharm Pharmacol 44: 456-458.
17. Giner-Larza EM, Manez S, Recio MC, Giner RM, Prieto JM, et al. (2001) Oleanonic acid, a 3-oxotriterpene from Pistacia, inhibits leukotriene synthesis and has anti-inflammatory activity. Eur J Pharmacol 428: 137-43.
18. Abdel-Zaher AO, Abdel-Rahman MM, Hafez MM, Faten M, Omran FM, et al. (2007) Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acidagainst acetaminophen-induced hepatic and renal damage. Toxicol 234: 124-134.
19. Patil CR, Jadhav RB, Singh PK, Mundada S, Patil PR, (2010) Protective effect of oleanolic acid on gentamicin induced nephrotoxicity in rats. Phytother Res 24: 154-159.
20. Hsu H-Y, Yang J-J, Lin C-C, (1997) Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 111: 7-13.
21. Kim YK, Yoon SK, Ryu SY, (2000) Cytotoxic triterpenes from stem bark of Physocarpus intermedius. Planta Med 66: 485-486.
22. Li J, Guo WJ, Yang QY, (2002) Effects of ursolic and oleanolic acid on human colon carcinoma cell line HCT 15. World J Gastroenterol 8: 493-495.
23. Zhang P, Li H, Chen D, Ni J, Kang Y, Wang S, (2007) Oleanolic Acid Induces Apoptosis in Human Leukemia Cells through Caspase Activation and Poly(ADP-ribose) Polymerase Cleavage. Acta Biochim Biophys Sin 39: 803-809.
24. Fernandes J, Castilho RO, Costa MR, Wagner-Souza K, Kaplan MA, et al. (2003) Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett 190: 165-169.
25. Torky ARW, Stehfest E, Viehweger K, Taege C, Foth H, (2005) Immuno-histochemical detection of MRPs in human lung cells in culture. Toxicol 207: 437-450.
26. Pešić M, Andjelković T, Banković J, Marković ID, Rakić L, et al. (2009) Sulfinosine enhances doxorubicin efficacy through synergism and by reversing multidrug resistance in the human non-small cell lung carcinoma cell line (NCI-H460/R). Invest New Drugs 27: 99-110.
27. Rocha GD, Simões M, Oliveira RR, Kaplan MA, Gattass CR, (2010) 3beta-acetyl tormentic acid induces apoptosis of resistant leukemia cells independently of P-gp/ABCB1 activity or expression. Invest New Drugs DOI 10.1007/s10637-010-9524-1 Published online.
28. Laupeze B, Amiot L, Courtois A, Vernhet L, Drenou B, et al. (1999) Use of the anionic dye carboxy-2′,7′-dichlorofluorescein for sensitive flow cytometric detection of multidrug resistance-associated protein activity. Int J Oncol 15: 571-576.
29. Sawada N, Kataoka K, Kondo K, Arimochi H, Fujino H, et al. (2004) Betulinic acid augments the inhibitory effects of vincristine on growth and lung metastasis of B16F10 melanoma cells in mice. Br J Cancer 90: 1672-1678.
30. Mickley LA, Bates SE, Richert ND, Currier LS, Tanakas S, et al. (1989) Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J Biol Chem 264: 18031-18040.
31. Gekeler V, Ise W, Sanders KH, Ulrich WR, Beck J, (1995) The Leukotriene LTD(4) Receptor Antagonist MK571 Specifically Modulates MRP Associated Multidrug-Resistance. Biochem Biophys Res Comm 208: 345-352.
32. Giaccone G, Van A-O J, Rubio GJ, Rubio GJ, Gazdar AF, et al. (1996) MRP is frequently expressed in human lung-cancer cell lines, in non-small-cell lung cancer and in normal lungs. Int J Cancer 66: 760-767.
33. Young LC, Campling BG, Voskoglou-Nomikos T, Cole SPC, Deeley RG, et al. (1999) Expression of Multidrug Resistance Protein-related Genes in Lung Cancer: Correlation with Drug Response. Clin Cancer Res 5: 673-680.
34. Young LC, Campling BG, Cole SPC, Deeley RG, Gerlach JH, (2001) Multidrug Resistance Proteins MRP3, MRP1, and MRP2 in Lung Cancer: Correlation of Protein Levels with Drug Response and Messenger RNA Levels. Clin Cancer Res 7: 1798-1804.
35. Braga F, Ayres-Saraiva D, Gattass CR, Capella MA, (2007) Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy. Cancer Lett 248: 147-152.
36. Fernandes J, Gattass CR, (2009) Topological Polar Surface Area Defines Substrate Transport by Multidrug Resistance Associated Protein 1 (MRP1/ABCC1). J Med Chem 52: 1214-1218.
37. Ikuta K, Takemura K, Kihara M, Naito S, Lee E, et al. (2005) Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells. Oncol Rep 13: (2005) 1229-1234.
38. Krysan K, Dalwadi H, Sharma S, Põld M, Dubinett SS, (2004) Cyclooxygenase 2-Dependent Expression of Survivin Is Critical for Apoptosis Resistance in Non-Small Cell Lung Cancer. Cancer Res 64: 6359-6362.
39. Mita CM, Mita MM, Nawrocki ST, Giles FJ, (2008) Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics. Clin Cancer Res 14: 5000-5005.
40. Luzzi KJ, MacDonald IC, Schmidt EE, kerkvliet N, Morris VL, et al. (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153: 865-873.
41. Mehrotra S, Languino LR, Raskett CM, Mercurio AM, Dohi T, et al. (2010) IAP Regulation of Metastasis. Cancer Cell 17: 53-64.
42. Mena S, Benlloch M, Ortega A, Carretero J, Obrador E, et al. (2007) Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease. Clin Cancer Res 13: 2658-66.
43. Hsu H-Y, Yang J-J, Lin C-C, (1997) Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett 111: 7-I3.
44. Liu J, (1995) Pharmacology of oleanolic acid and ursolic acid. J Ethnopharmacol 49: 57-68.